Trial intelligence / Profile preview

Elidel vs Clobetasol for Vulvar Lichen Sclerosus

NCT00393263Phase 2Completed

Sponsor
The Centers for Vulvovaginal Disorders
Start
Oct 2006
Primary completion
Oct 2009
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of pimecrolimus in vulvar lichen sclerosus (LS), sponsored by The Centers for Vulvovaginal Disorders. Started Oct 2006; status: completed.

02

Drugs

pimecrolimus
03

Conditions

vulvar lichen sclerosus (LS)

Beyond the preview

Go deeper on NCT00393263.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00393263.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call